Medacta Group SA (LON:0A05)

London flag London · Delayed Price · Currency is GBP · Price in CHF
137.60
-0.40 (-0.29%)
Feb 21, 2025, 9:52 AM BST
5.42%
Market Cap 2.41B
Revenue (ttm) 461.46M
Net Income (ttm) 47.66M
Shares Out n/a
EPS (ttm) 2.38
PE Ratio 50.52
Forward PE n/a
Dividend 0.48 (0.35%)
Ex-Dividend Date May 10, 2024
Volume 77
Average Volume 1,883
Open 137.40
Previous Close 138.00
Day's Range 137.60 - 137.60
52-Week Range 95.70 - 137.60
Beta 1.22
RSI 74.31
Earnings Date Mar 25, 2025

About Medacta Group

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine procedures. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland. [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1958
Employees 1,730
Stock Exchange London Stock Exchange
Ticker Symbol 0A05
Full Company Profile

Financial Performance

In 2023, Medacta Group's revenue was 510.78 million, an increase of 16.85% compared to the previous year's 437.12 million. Earnings were 47.36 million, an increase of 2.41%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.